BiotechTube

Olaratumab

Pre-clinicalCompleted
0 watching 0 views this week💤 Quiet
23
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Soft Tissue Sarcoma

Conditions

Soft Tissue Sarcoma

Trial Timeline

— → —

NCT ID
NCT03994627

About Olaratumab

Olaratumab is a pre-clinical stage product being developed by Eli Lilly for Soft Tissue Sarcoma. The current trial status is completed. This product is registered under clinical trial identifier NCT03994627. Target conditions include Soft Tissue Sarcoma.

Hype Score Breakdown

Clinical
5
Activity
2
Company
10
Novelty
2
Community
1

Clinical Trials (3)

NCT IDPhaseStatus
NCT03994627Pre-clinicalCompleted
NCT01316263Phase 2Terminated
NCT01199822Phase 1Completed

Competing Products

20 competing products in Soft Tissue Sarcoma

See all competitors
ProductCompanyStageHype Score
Olaratumab + Doxorubicin + Ifosfamide + MesnaEli LillyPhase 1
33
Anlotinib HydrochlorideSun PharmaceuticalPhase 2
52
Eribulin mesylate 1.4 mg/m^2 intravenous + Dacarbazine of 850 mg/m^2, or 1,000 mg/m^2, or 1,200 mg/m^2 IVEisaiPhase 3
77
Eribulin mesylateEisaiPre-clinical
23
E7389EisaiPhase 2
52
eribulin mesylateEisaiPhase 2
52
Olaratumab + Gemcitabine + Docetaxel + PlaceboEli LillyPhase 1/2
41
LY573636-sodiumEli LillyPhase 2
52
Olaratumab + Doxorubicin + PlaceboEli LillyPhase 3
77
Olaratumab + DoxorubicinEli LillyPhase 1
33
Olaratumab + DoxorubicinEli LillyPhase 1
33
Olaratumab + Pembrolizumab (KEYTRUDA®)Eli LillyPhase 1
33
Olaratumab + doxorubicinEli LillyPhase 1/2
41
TrabectedinJohnson & JohnsonPre-clinical
23
Doxorubicin + Trabectedin + DexamethasoneJohnson & JohnsonPhase 1
33
Apatinib Mesylate, doxorubicin, ifosfamideJiangsu Hengrui MedicinePhase 2
52
Camrelizumab in Combination With Neoadjuvant ChemotherapyJiangsu Hengrui MedicinePhase 2
52
Durvalumab and Tremelimumab + DoxorubicinAstraZenecaPhase 2
52
Standard arm: Trabectedin in monotherapy + Experimental arm: Trabectedin + OlaparibAstraZenecaPhase 2
52
trabectedin + olaparibAstraZenecaPhase 1
33

Other Products from Eli Lilly

Insulin Glargine + Insulin Lispro Premix (mid-mixture and low-mixture)Approved
85
Olanzapine + PlaceboApproved
85
exenatide and sitagliptin + exenatide and placeboApproved
85
Tirzepatide + PlaceboApproved
85
tadalafilApproved
85